miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR-137 inhibits glutamine catabolism and growth of malignant melanoma by targeting glutaminase

Published:2018-01 Issue:1 Volume:495 Page:46-52
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Luan Wenkang^ORCID,Zhou Zhou,Zhu Yan,Xia Yun,Wang Jinlong,Xu Bin

Funder

The Social Development and Technology Support Foundation of Zhenjiang city

The Clinical Medical Science and Technology Development Fund of Jiangsu University

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference23 articles.

1. Melanoma never says die;Haass;Exp. Dermatol,2014

2. Metastatic melanoma: insights into the evolution of the treatments and future challenges;Millet;Med. Res. Rev.,2017

3. Update on the current state of melanoma incidence;Little;Dermatol Clin.,2012

4. Malignant melanoma in elderly patients: biological, surgical and medical issues;Russo;Expert Rev. Anticancer Ther.,2015

5. Signal transduction in human cutaneous melanoma and target drugs;Uzdensky;Curr. Cancer Drug Targets,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial Raf1 Regulates Glutamine Catabolism;2024-03-09

2. A prognostic model based on DNA methylation-related gene expression for predicting overall survival in hepatocellular carcinoma;Frontiers in Oncology;2024-01-18

3. miR-224–5p acts as a tumour suppressor and reverses the resistance to BRAF inhibitor in melanoma through directly targeting PAK4 to block the MAPK pathway;Pathology - Research and Practice;2023-09

4. Association between GLS Gene Polymorphisms and the Susceptibility to Lung Cancer in the Chinese Han Population;Frontiers in Bioscience-Landmark;2023-05-22

5. Alone and together: current approaches to targeting glutaminase enzymes as part of anti-cancer therapies;Future Drug Discovery;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3